Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04025320 · ClinicalTrials.gov registry record · NA
The Effect of Intraneural Facilitation Therapy on Diabetic Patients With Peripheral Neuropathy
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04025320 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 30 participants.
The verdict
NCT04025320, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this graduate student research study is to explore the effects of a new treatment known as Intraneural facilitation (INF) on Diabetes Mellitus Type 2 (DMT2) subjects who have moderate - severe below ankle neuropathy symptoms. Since INF has shown success in the clinic and significant improvements have been found in a recent pilot study, this study aims to further explore these effects on DMT2 subjects suffering from DPN. The investigators would like to investigate if INF improves blood flow in the foot, if it decreases the pain and improves the sensation, and if it improves the overall quality of life.
Interventions
- OTHER Sham
- OTHER Intraneural Facilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-09-27 |
| Est. Completion | 2020-12-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04025320
The ClinicalTrials.gov registry entry for NCT04025320 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham is the first listed.
NCT04025320 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04025320 about?
NCT04025320 is a clinical study titled "The Effect of Intraneural Facilitation Therapy on Diabetic Patients With Peripheral Neuropathy". The purpose of this graduate student research study is to explore the effects of a new treatment known as Intraneural facilitation (INF) on Diabetes Mellitus Type 2 (DMT2) subjects who have moderate - severe below ankle neuropathy symptoms. Since INF has shown success in the clinic and significant i...
What is the current status of trial NCT04025320?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2019-09-27. Estimated completion is 2020-12-10.
What interventions are being tested in trial NCT04025320?
The interventions under investigation include: Sham (OTHER), Intraneural Facilitation (OTHER).
Who is sponsoring clinical trial NCT04025320?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.